Glaucoma: Diagnosis and Management.
Michels TC, Ivan O.
Am Fam Physician. 2023 Mar;107(3):253-262.
Association between Glucagon-like Peptide-1 Receptor Agonists and the Risk of Glaucoma in Individuals with Type 2 Diabetes.
Niazi S, Gnesin F, Thein AS, Andreasen JR, Horwitz A, Mouhammad ZA, Jawad BN, Niazi Z, Pourhadi N, Zareini B, Meaidi A, Torp-Pedersen C, Kolko M.
Ophthalmology. 2024 Sep;131(9):1056-1063. doi: 10.1016/j.ophtha.2024.03.004. Epub 2024 Mar 13.
Incidence of Glaucoma in Type 2 Diabetes Patients Treated With GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis.
Asif M, Asif A, Rahman UA, Farooqi HA, Fatima O, Ali W, Jafar U, Jaber MH.
Endocrinol Diabetes Metab. 2025 Jul;8(4):e70059. doi: 10.1002/edm2.70059.
Smartphone-Assisted Glaucoma Screening in Patients With Type 2 Diabetes: a Pilot Study.
Bilong Y, Domngang CN, Nwanlih Gimma G, Katte JC, Afetane TE, Kagmeni G, Mbanya JC, Kumar N, Sharma A, Sobngwi E.
Med Hypothesis Discov Innov Ophthalmol. 2020;9(1):61-65. Epub 2020 Jan 1.
Assessment of iris volume in glaucoma patients with type 2 diabetes mellitus by AS-OCT.
Su Y, Ge QS, Li ZY, Bu QW, Hu D, Zhou LF, Pan XJ.
Int J Ophthalmol. 2023 May 18;16(5):743-747. doi: 10.18240/ijo.2023.05.11. eCollection 2023.
Association of Primary Open-Angle Glaucoma with Diabetic Retinopathy among Patients with Type 1 and Type 2 Diabetes: A Large Global Database Study.
Chauhan MZ, Elhusseiny AM, Kishor KS, Sanvicente CT, Ali AA, Sallam AB, Bhattacharya SK, Uwaydat SH.
Ophthalmology. 2024 Jul;131(7):827-835. doi: 10.1016/j.ophtha.2024.01.016. Epub 2024 Jan 10.
Aloe-emodin: A review of its pharmacology, toxicity, and pharmacokinetics.
Dong X, Zeng Y, Liu Y, You L, Yin X, Fu J, Ni J.
Phytother Res. 2020 Feb;34(2):270-281. doi: 10.1002/ptr.6532. Epub 2019 Nov 3.
Comparative Effects of Glucagon-like Peptide 1 Receptor Agonists and Metformin on Glaucoma Risk in Patients with Type 2 Diabetes.
Muayad J, Loya A, Hussain ZS, Chauhan MZ, Alsoudi AF, De Francesco T, Ahmed IIK.
Ophthalmology. 2025 Mar;132(3):271-279. doi: 10.1016/j.ophtha.2024.08.023. Epub 2024 Aug 23.
Association between sodium glucose co-transporter 2 inhibitors and incident glaucoma in patients with type 2 diabetes: A multi-institutional cohort study in Taiwan.
Shao SC, Su YC, Lai EC, Chang KC, Lee CN, Hung MJ, Lai CC, Huang FC, Hung JH.
Diabetes Metab. 2022 Jan;48(1):101318. doi: 10.1016/j.diabet.2022.101318. Epub 2022 Jan 8.
Prevalence and Associated Risk Factors of Primary Open Angle Glaucoma Among Patients With Type 2 Diabetes Mellitus: A Cross-Sectional Study From North India.
Singh W, Singh Salaria N, Pandey ML, Bhandari V, Singh S, Bhardwaj P.
Cureus. 2022 Sep 7;14(9):e28908. doi: 10.7759/cureus.28908. eCollection 2022 Sep.
